The FDA's approval of the first CRISPR-Cas9–based gene therapy marked a major milestone in biomedicine, validating genome ...

In two studies of mice, a molecule called leukotriene helped trigger food-induced anaphylaxis. A drug approved for asthma — zileuton — diminished it.